EICHORCondition: DLBCL · Sponsor: Fondazione Italiana Linfomi - ETS
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a prospective, multicenter, single arm, phase II trial in patients with ≥ 18 and \<65 years with poor-prognosis (IPI ≥ 2) and newly diagnosed ABC-DLBCL. Aim of the study is to assess the efficacy and the safety of R-CHOP in combination with ibrutinib for 6 cycles followed by ibrutinib maintenance for 18 months in ABC-DLBCL patients achieving at least a PR after the induction phase
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Ospedale di Castelfranco Veneto - Oncoematologia IOV | Castelfranco Veneto, Treviso, Italy | — |
| A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia | Alessandria, Italy | — |
| Università Politecnica delle Marche- Clinica di Ematologia | Ancona, Italy | — |
| Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico | Avellino, Italy | — |
| Centro Riferimento Oncologico- S.O.C. Oncologia Medica A | Aviano, Italy | — |
| IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia | Bari, Italy | — |
| ASST Spedali Civili di Brescia - Ematologia | Brescia, Italy | — |
| Ospedale Businco - SC Ematologia e CTMO | Cagliari, Italy | — |
| Arnas Nuovo Ospedale Garibaldi Nesima - U.O.C. Ematologia | Catania, Italy | — |
| Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia | Florence, Italy | — |
| Ospedale Policlinico San Martino S.S.R.L- IRCCS per l'Oncologia - Ematologia | Genova, Italy | — |
| Azienda Ospedali Riuniti Papardo-Piemonte - S.C. Ematologia | Messina, Italy | — |
+ 27 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03731234